Europe Venous Diseases Treatment Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
USD 1,264.21 million |
 Market Size (Forecast Year) |
USD 2,535.02 million |
 CAGR |
% |
| Major Markets Players |
Europe Venous Diseases Treatment Market, By Product Type (Sclerotherapy Injection, Ablation Devices, Venous Closure Products, Venous Stents, Medication and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others), Treatment Type (Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation and stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, Venoactive Medication, Vena Cava Filter and Others Therapies), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2030.
Europe Venous Diseases Treatment Market Analysis and Insights
Venous disease includes blood clots in the legs, arms, brain, lungs or internal organs such as kidney, spleen, liver, deep vein thrombosis, chronic venous insufficiency, varicose veins, and veins, and ulcers in the veins. Treatment for this disease includes drug therapy, endogenous laser ablation or radiofrequency ablation (RFA), sclerotherapy, and surgery.
Data Bridge Market Research analyzes that the Europe venous diseases treatment market is expected to reach the value of USD 2,535.02 million by 2030, at a CAGR of 6.8% during the forecast period. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2020-1015) |
|
Quantitative Units |
Revenue in Million, Pricing in USD |
|
Segments Covered |
By Product Type (Sclerotherapy Injection, Ablation Devices, Venous Closure Products, Venous Stents, Medication and Others), Disease Type (Deep Vein Thrombosis (DVT), Chronic Venous Insufficiency (CVI), Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others), Treatment Type (Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation and stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, Venoactive Medication, Vena Cava Filter and Others Therapies), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) |
|
Countries Covered |
Germany, France, Russia, Italy, U.K., Spain, Turkey, Netherlands, Belgium, Switzerland, Israel, and Rest of Europe |
|
Market Players Covered |
Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex incorporated, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips N.V., Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems and Bolitec Laser among others. |
Europe Venous Diseases Treatment Market Definition
Heart attacks, and strokes are usually acute events, and are primarily caused by a blockage that blocks blood flow to the heart or brain. The most common cause is the build-up of fatty deposits in the lining of the blood vessels that supply the heart or brain. A stroke can be caused by bleeding or blood clots in a blood vessel in the brain.
Technological advancements in vascular stents, increase in demand for minimally invasive procedures, and rise in geriatric population are driving the Europe market. Moreover, the companies are expanding their product portfolio to offer the best services for venous diseases treatment. Medical devices such as ablation devices are used in minimally invasive procedures to remove or excise abnormal body tissues for therapeutic purposes. These systems use the heat generated by radio frequency, energy, extreme cold, or a laser to cause small burns. Rise in adoption of robotic technologies for product application expansion, and integration of cutting-edge technologies in ablation devices to improve patient safety, and procedural efficiency are expected to drive the market.
Europe Venous Diseases Treatment Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Rising incidences of venous diseases
Venous diseases are the conditions that damage veins in body. Damaged blood vessel walls prevent the circulatory system from working, causing blood to pool and reflux (backwards) when the muscles relax. This causes abnormally high pressure to build up in the veins. This build-up causes veins to tighten and twist, increased swelling, increased valve incompetence, slow blood flow, and possible blood clots. Finally, this condition can lead to various diseases known as venous diseases.
Due to various risk factors such as ageing, obesity, high blood pressure (hypertension) or family history of venous disease, patients with venous diseases are rising globally and becoming a significant socio-economic issue. Thus the rising number of patients with venous diseases increases the demand for venous diseases treatment which act as a driver in the Europe venous diseases treatment market.
- Rapid changes in lifestyle leads to obesity resulting in venous diseases
Lifestyle changes such as smoking, unhealthy diet and physical inactivity lead to the development of chronic diseases, especially heart disease, stroke, diabetes, obesity and metabolic syndrome that can eventually result in venous diseases.
Physical activity is essential and many conditions are a direct result of a sedentary lifestyle. Sedentary lifestyle may result in gain weight, tire easily and have unexplained aches and pains that develop chronic condition, including cardiovascular and venous disease, ranging from moderate, severe or even life-threatening.
According to the article of ScienceDirect, venous disease was more clinically severe in the obese limbs than non-obese group. Thus due to increase in adoption of unhealthy lifestyle there is rapid increase in obese population with venous diseases rising. Thus the rapid changes in lifestyle leads to obesity resulting in venous diseases which increases the demand for venous diseases treatment and act as a driver in the Europe venous diseases treatment market.
Restraint
- Lack of skilled and certified professionals
The requirement of skilled and certified professionals is a big restraint for venous diseases treatment market. The demand for venous disease treatment is increased due to increasing cases of venous diseases in the Europe but the less number of skilled professionals present in the healthcare center is hampering the growth of the market.
Chronic venous disease (CVD) is often overlooked by healthcare professionals because they do not understand the extent and impact of the problem, and the different manifestations of primary and secondary venous disease are not fully recognized. The importance of cardiovascular diseases is related to the number of patients and to the socio-economic effects of its more serious manifestations.
Opportunity
- Rising awareness towards venous disorders
Both medicinal procedures and lifestyle changes can be used to treat vein problems. Your veins can benefit from medication, exercise, and compression stockings, but occasionally vein problems necessitate more thorough therapy to restore the health and performance of your veins. The course of treatment is determined by the kind and severity of the venous disease. Patients with vascular disorders have increased dramatically over the past few decades, with diabetes serving as the most flagrant risk factor. Unlike other health problems, vascular disorders and vascular surgery are unknown to approximately 80% of the population. People's attitudes and behaviours about particular illnesses can change significantly as a result of increased health awareness.
There are several awareness programs are conducted by various societies, government institutes and others. These initiatives taken by them will increase awareness among people regarding their health and take early diagnosis for better cure and precaution. For this reason, rising awareness towards venous disorders are expected to act as an opportunity for growing the demand of the Europe venous diseases treatment market.
Challenge
- High cost associated with venous disease treatment
More than 25 million persons in the United States alone suffer from chronic venous insufficiency (CVI), with more than 6 million having advanced venous illness. The US healthcare system is heavily burdened financially as a result of the high incidence of CVI and rising healthcare costs. Numerous widespread health issues are caused by poor venous circulation. Leg pain, edoema, and heaviness are some of the early signs of chronic venous disease (CVD), and they can be present all day long or become more pronounced in the evening. Patients frequently seek out initial therapy for symptoms that might occur with or without varicose veins, as well as for cosmetic varicose vein removal. The two main risk factors for CVD are advancing age and high body mass.
Post-COVID-19 Impact on Europe Venous Diseases Treatment Market
The pandemic has had adverse impacts on the manufacturers as well as users. As varicose veins procedures are non-urgent, the volume of procedures declined drastically. Reduction in the surgeries or procedures for the treatment of varicose veins due to traveling restrictions also impacted the sales of the manufacturers.
Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launch and strategic partnerships to improve the technology and test results involved in the pet food flavors and ingredients market.
Recent Developments
- In July 2022, Smith+Nephew, the Europe medical technology company has launches Clinical Support App to help reduce practice variation in wound care. The WOUND COMPASS Clinical Support App is a comprehensive digital support tool for health care professionals that aids wound assessment and decision-making to help reduce practice variation. This has helped the company to attract the healthcare customers and expand product portfolio
- In April 2022, Carl Zeiss Meditec has announced the acquisition of two manufacturers of surgical instruments (Kogent Surgical, LLC and Katalyst Surgical, LLC) to further strengthen its positioning as a solution provider. This has helped the company to expand their business
Europe Venous Diseases Treatment Market Scope
Europe venous diseases treatment market is segmented into product type, disease type, treatment type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
EUROPE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE
- ABLATION DEVICES
- VENOUS STENTS
- VENOUS CLOSURE PRODUCTS
- SCLEROTHERAPY INJECTION
- MEDICATIONS
- OTHERS
On the basis of product type, the Europe venous diseases treatment market is segmented into ablation devices, venous stents, venous closure products, sclerotherapy injection, medications, and others.
EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE
- DEEP VEIN THROMBOSIS (DVT)
- CHRONIC VENOUS INSUFFICIENCY (CVI)
- PULMONARY EMBOLISM
- SUPERFICIAL THROMBOPHLEBITIS
- VARICOSE VEINS
- OTHERS
On the basis of disease type, the Europe venous diseases treatment market is segmented into deep vein thrombosis (DVT), chronic venous insufficiency (CVI), pulmonary embolism, superficial thrombophlebitis, varicose veins, and others.
EUROPE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE
- COMPRESSION THERAPY
- VENO ACTIVE MEDICATION
- SURGERIES
- SCLEROTHERAPY
- ANGIOPLASTY OR STENTING
- VEIN LIGATION AND STRIPPING
- VENA CAVA FILTER
- AMBULATORY PHLEBECTOMY
- RADIOFREQUENCY ABLATION THERAPY
- LASER TREATMENT
- OTHERS THERAPIES
On the basis of treatment type, the Europe venous diseases treatment market is segmented into compression therapy, veno active medication, surgeries, scelrotherapy, angioplasty or stenting, vein legation, and stripping, vena cava filter, ambulatory phlebectomy, radiofrequency ablation therapy, laser treatment, and other therapies.
EUROPE VENOUS DISEASES TREATMENT MARKET, BY END USER
- HOSPITALS
- CLINICS
- AMBULATORY SURGICAL CENTERS
- OTHERS
On the basis of end user, the Europe venous diseases treatment market is segmented into hospitals, clinics, ambulatory surgical centers, and others.
EUROPE VENOUS DISEASES TREATMENTS MARKET, BY DISTRIBUTION CHANNEL
- DIRECT TENDER
- RETAIL SALES
- OTHERS
On the basis of distribution channel, the Europe venous diseases treatment market is segmented into direct tender, retail sales, and others.
Europe Venous Diseases Treatment Market Regional Analysis/Insights
The Europe venous diseases treatment market is analyzed and market size information is provided product type, disease type, treatment type, end user, and distribution channel.
The countries covered in this market report Germany, France, Russia, Italy, U.K., Spain, Turkey, Netherlands, Belgium, Switzerland, Israel, and Rest of Europe.
Germany is dominating Europe region due to the mass production of venous disease treatment drugs and increasing demand from emerging markets and expansion of venous disease treatment industries.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Venous Diseases Treatment Market Share Analysis
Europe venous diseases treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Europe venous diseases treatment market.
Some of the major players operating in the Europe venous diseases treatment market are Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex incorporated, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips N.V., Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems, Bolitec Laser among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE VENOUS DISEASES TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 INSTRUMENT BASED LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 EUROPE VENOUS DISEASES TREATMENT MARKET, INDUSTRY INSIGHTS
6 EPIDEMIOLOGY
7 REGULATORY FRAMEWORK
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISING INCIDENCES OF VENOUS DISEASES
8.1.2 RAPID CHANGES IN LIFESTYLE LEAD TO OBESITY RESULTING IN VENOUS DISEASES
8.1.3 INCREASE IN THE GERIATRIC POPULATION
8.1.4 TECHNOLOGICALLY ADVANCEMENT IN THE TREATMENT OF VENOUS DISEASES
8.2 RESTRAINTS
8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
8.2.2 INADEQUATE REIMBURSEMENT COVERAGE
8.3 OPPORTUNITIES
8.3.1 RISING AWARENESS TOWARDS VENOUS DISORDERS
8.3.2 NEED FOR PROPER DIAGNOSIS AND TREATMENT OF VENOUS DISEASES
8.3.3 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
8.3.4 OCCUPATIONAL LIFESTYLE INCREASES THE NEED FOR VENOUS DISEASE TREATMENT
8.4 CHALLENGES
8.4.1 HIGH COST ASSOCIATED WITH VENOUS DISEASE TREATMENT
8.4.2 SIDE EFFECTS AND RISK ASSOCIATED WITH DIFFERENT TREATMENT MODES
9 EUROPE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 SCLEROTHERAPY INJECTION
9.2.1 SCLEROTHERAPY, BY TYPE
9.2.1.1 INTRAVENOUS
9.2.1.2 INTRADERMAL
9.2.1.3 SUBCUTANEOUS
9.2.2 SUBCUTANEOUS, BY APPLICATION
9.2.2.1 MALFORMED LYMPHED VESSELS
9.2.2.2 HEMORRHOIDS
9.2.2.3 HYDROCELES
9.2.2.4 OTHERS
9.3 ABLATION DEVICES
9.3.1 THERMAL ABLATION
9.3.1.1 RADIOFREQUENCY
9.3.1.1.1 CATHETER MANIPULATION SYSTEMS
9.3.1.1.2 TEMPERATURE CONTROLLED
9.3.1.1.3 FLUID COOLED
9.3.1.2 LIGHT
9.3.1.2.1 EXCIMER LASERS
9.3.1.2.2 COLD LASERS
9.3.1.3 ULTRASOUND
9.3.1.3.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)
9.3.1.3.2 SHOCK WAVE LITHOTRIPSY
9.3.1.3.3 MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND (MRI-FUS)
9.3.1.3.4 ULTRASONIC SURGICAL SYSTEMS
9.3.1.4 RADIATION
9.3.1.4.1 STEREOTACTIC BODY RADIATION THERAPY
9.3.1.4.2 INTENSITY-MODULATED RADIATION THERAPY
9.3.1.4.3 STEREOTACTIC RADIOTHERAPY & RADIOSURGERY
9.3.1.4.4 IMAGE GUIDED RADIATION THERAPY
9.3.1.4.5 INTRAVASCULAR BRACHYTHERAPY
9.3.1.4.6 PROTON BEAM THERAPY
9.3.1.5 ELECTRICAL
9.3.1.5.1 ELECTRICAL ABLATORS
9.3.1.5.2 ELECTRONIC BRACHYTHERAPY
9.3.1.6 MICROWAVE
9.3.1.7 HYDROTHERMAL
9.3.2 NON-THERMAL ABLATION
9.3.2.1 CRYOABLATION
9.3.2.1.1 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
9.3.2.1.2 CRYOGEN SPRAY PROBE
9.3.2.1.3 TISSUE CONTACT PROBE
9.3.2.2 HYDROMECHANICAL ABLATION
9.4 VENOUS CLOSURE PRODUCTS
9.4.1 VENOUS CLOSURE PRODUCTS, BY PROCEDURE
9.4.1.1 INTERVENTIONAL CARDIOLOGY
9.4.1.2 INTERVENTIONAL RADIOLOGY
9.4.2 VENOUS CLOSURE PRODUCTS, BY TECHNOLOGY
9.4.2.1 FEMORAL ACCESS TECHNIQUE
9.4.2.2 RADIAL ACCESS TECHNIQUE
9.5 VENOUS STENTS
9.5.1 VENOUS STENTS, BY TECHNOLOGY
9.5.1.1 WALLSTENT TECHNOLOGY
9.5.1.2 ILIAC VEIN STENT TECHNOLOGY
9.5.2 VENOUS STENTS, BY APPLICATION
9.5.2.1 LEG
9.5.2.2 CHEST
9.5.2.3 ABDOMEN
9.5.2.4 OTHERS
9.6 MEDICATION
9.7 OTHERS
10 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE
10.1 OVERVIEW
10.2 VARICOSE VEINS
10.3 DEEP VEIN THROMBOSIS (DVT)
10.4 PULMONARY EMBOLISM
10.5 CHRONIC VENOUS INSUFFICIENCY (CVI)
10.6 SUPERFICIAL THROMBOPHLEBITIS
10.7 OTHERS
11 EUROPE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE
11.1 OVERVIEW
11.2 SCLEROTHERAPY
11.3 RADIOFREQUENCY ABLATION THERAPY
11.4 LASER TREATMENT
11.5 AMBULATORY PHLEBECTOMY
11.6 VEIN LIGATION AND STRIPPING
11.7 ANGIOPLASTY OR STENTING
11.8 SURGERIES
11.9 COMPRESSION THERAPY
11.1 VEINACTIVE MEDICATION
11.11 VENA CAVA FILTER
11.12 OTHER THERAPIES
12 EUROPE VENOUS TREATMENT DISEASES MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 OTHERS
13 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 EUROPE VENOUS DISEASES TREATMENT MARKET, BY REGION
14.1 EUROPE
14.1.1 GERMANY
14.1.2 U.K.
14.1.3 FRANCE
14.1.4 ITALY
14.1.5 RUSSIA
14.1.6 SPAIN
14.1.7 TURKEY
14.1.8 NETHERLANDS
14.1.9 BELGIUM
14.1.10 SWITZERLAND
14.1.11 IRELAND
14.1.12 REST OF EUROPE
15 EUROPE VENOUS DISEASES TREATMENT MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: EUROPE
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 MEDTRONIC
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 BOSTON SCIENTIFIC CORPORATION
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 VARIAN MEDICAL SYSTEMS, INC.
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 STRYKER
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 KONINKLIJKE PHILIPS N.V.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 ABBOTT
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 ALMA LASERS
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANGIODYNAMICS
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 B.BRAUN MELSUNGEN AG
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 BAYLIS MEDICAL COMPANY, INC
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 BD
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 CANDELA MEDICAL
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 CARL ZEISS MEDITEC AG
17.13.1 COMPANYSNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 COOK
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 IMRICOR
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.16 OLYMPUS CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOILIO
17.16.4 RECENT DEVELOPMENT
17.17 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 PLUSMEDICA.DE
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 SCITECH
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 SMITH + NEPHEW
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENT
17.21 SONABLATE
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 THERACLION
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 TELEFLEX INCORPORATED
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 TERUMO CORPORATION
17.24.1 COMPANY SNAPSHOT
17.24.2 REVENUE ANALYSIS
17.24.3 PRODUCT PORTFOLIO
17.24.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 EUROPE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 5 EUROPE ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 EUROPE THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 EUROPE ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 EUROPE ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 EUROPE NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 EUROPE CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 17 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 18 EUROPE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 20 EUROPE ILIAC VEIN STENT TECHNOLOGY IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 21 EUROPE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 24 EUROPE VARICOSE VEINS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 EUROPE DEEP VEIN THROMBOSIS (DVT) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE PULMONARY EMBOLISM IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE CHRONIC VENOUS INSUFFICIENCY (CVI) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE SUPERFICIAL THROMBOPHLEBITIS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 31 EUROPE SCELEROTHERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 EUROPE RADIOFREQUENCY ABLATION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 EUROPE LASER TREATMENT IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 EUROPE AMBULATORY PHELEBECTOMY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 EUROPE VEIN LIGATION AND STRIPPING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 EUROPE ANGIOPLASTY OR STENTING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 EUROPE SURGERIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 EUROPE COMPRESSION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 EUROPE VEINACTIVE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 EUROPE VENA CAVA FILTER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 EUROPE OTHER THERAPIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 EUROPE VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 43 EUROPE HOSPITALS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 EUROPE CLINICS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 EUROPE AMBULATORY SURGICAL CENTERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 EUROPE OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 EUROPE DIRECT TENDER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 EUROPE RETAIL SALES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 EUROPE OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 EUROPE VENOUS DISEASES TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 52 EUROPE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 53 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 EUROPE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 EUROPE ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 EUROPE THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 EUROPE RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 EUROPE LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 59 EUROPE ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 60 EUROPE RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 EUROPE ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 EUROPE NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 EUROPE CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 65 EUROPE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 66 EUROPE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 67 EUROPE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 68 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 69 EUROPE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 70 EUROPE VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 EUROPE VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 72 GERMANY VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 73 GERMANY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 74 GERMANY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 GERMANY ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 GERMANY THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 77 GERMANY RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 78 GERMANY LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 GERMANY ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 GERMANY RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 GERMANY ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 GERMANY NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 GERMANY CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 GERMANY VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 85 GERMANY VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 86 GERMANY VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 87 GERMANY VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 GERMANY VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 89 GERMANY VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 90 GERMANY VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 GERMANY VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 U.K. VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 U.K. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 94 U.K. SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 U.K. ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 U.K. THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 U.K. RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.K. LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 U.K. ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.K. RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 U.K. ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 U.K. NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 103 U.K. CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 104 U.K. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 105 U.K. VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 106 U.K. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 107 U.K. VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 U.K. VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 109 U.K. VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 110 U.K. VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 U.K. VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 112 FRANCE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 FRANCE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 FRANCE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 115 FRANCE ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 FRANCE THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 FRANCE RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 FRANCE LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 FRANCE ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 120 FRANCE RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 FRANCE ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 FRANCE NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 FRANCE CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 FRANCE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 125 FRANCE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 126 FRANCE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 127 FRANCE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 128 FRANCE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 129 FRANCE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 130 FRANCE VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 FRANCE VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 ITALY VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 ITALY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 134 SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 135 ITALY ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 ITALY THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 ITALY RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 ITALY LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 ITALY ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 ITALY RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 141 ITALY ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 ITALY NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 143 ITALY CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 ITALY VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 145 ITALY VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 146 ITALY VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 147 ITALY VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 148 ITALY VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 149 ITALY VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 150 ITALY VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 ITALY VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 152 RUSSIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 RUSSIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 RUSSIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 155 RUSSIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 156 RUSSIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 157 RUSSIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 RUSSIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 RUSSIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 RUSSIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 RUSSIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 RUSSIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 RUSSIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 RUSSIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 165 RUSSIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 166 RUSSIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 167 RUSSIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 168 RUSSIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 169 RUSSIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 170 RUSSIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 171 RUSSIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 172 SPAIN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 173 SPAIN SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 SPAIN SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 SPAIN ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 176 SPAIN THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 177 SPAIN RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 SPAIN LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 179 SPAIN ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 180 SPAIN RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 SPAIN ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 SPAIN NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 SPAIN CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 SPAIN VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 185 SPAIN VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 186 SPAIN VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 187 SPAIN VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 188 SPAIN VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 189 SPAIN VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 190 SPAIN VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 191 SPAIN VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 192 TURKEY VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 193 TURKEY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 194 TURKEY SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 195 TURKEY ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 TURKEY THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 TURKEY RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 TURKEY LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 TURKEY ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 200 TURKEY RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 TURKEY ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 TURKEY NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 203 TURKEY CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 TURKEY VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 205 TURKEY VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 206 TURKEY VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 207 TURKEY VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 208 TURKEY VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 TURKEY VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 210 TURKEY VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 211 TURKEY VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 212 NETHERLANDS VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 NETHERLANDS SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 214 NETHERLANDS SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 NETHERLANDS ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 216 NETHERLANDS THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 NETHERLANDS RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 NETHERLANDS LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 219 NETHERLANDS ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 NETHERLANDS RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 NETHERLANDS ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 222 NETHERLANDS NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 223 NETHERLANDS CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 224 NETHERLANDS VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 225 NETHERLANDS VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 226 NETHERLANDS VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 227 NETHERLANDS VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 NETHERLANDS VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 229 NETHERLANDS VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 230 NETHERLANDS VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 231 NETHERLANDS VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 232 BELGIUM VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 233 BELGIUM SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 234 BELGIUM SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 235 BELGIUM ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 BELGIUM THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 237 BELGIUM RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 BELGIUM LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 239 BELGIUM ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 BELGIUM RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 241 BELGIUM ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 BELGIUM NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 BELGIUM CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 244 BELGIUM VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 245 BELGIUM VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 246 BELGIUM VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 247 BELGIUM VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 BELGIUM VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 249 BELGIUM VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 250 BELGIUM VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 251 BELGIUM VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 252 SWITZERLAND VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 253 SWITZERLAND SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 254 SWITZERLAND SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 255 SWITZERLAND ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 SWITZERLAND THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 257 SWITZERLAND RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 258 SWITZERLAND LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 SWITZERLAND ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 260 SWITZERLAND RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 261 SWITZERLAND ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 SWITZERLAND NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 SWITZERLAND CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 264 SWITZERLAND VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 265 SWITZERLAND VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 266 SWITZERLAND VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 267 SWITZERLAND VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 268 SWITZERLAND VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 269 SWITZERLAND VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 270 SWITZERLAND VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 271 SWITZERLAND VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 272 IRELAND VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 273 IRELAND SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 274 IRELAND SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 275 IRELAND ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 276 IRELAND THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 277 IRELAND RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 278 IRELAND LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 279 IRELAND ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 IRELAND RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 IRELAND ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 282 IRELAND NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 283 IRELAND CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 284 IRELAND VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 285 IRELAND VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 286 IRELAND VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 287 IRELAND VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 288 IRELAND VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 289 IRELAND VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 290 IRELAND VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 291 IRELAND VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 292 REST OF EUROPE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 EUROPE VENOUS DISEASES TREATMENT MARKET: SEGMENTATION
FIGURE 2 EUROPE VENOUS DISEASES TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE VENOUS DISEASES TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE VENOUS DISEASES TREATMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE VENOUS DISEASES TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE VENOUS DISEASES TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE VENOUS DISEASES TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 EUROPE VENOUS DISEASES TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE VENOUS DISEASES TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE VENOUS DISEASES TREATMENT MARKET: SEGMENTATION
FIGURE 11 GROWING AWARENESS ABOUT VENOUS DISEASES TREATMENTS AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE VENOUS DISEASES TREATMENT MARKET FROM 2023 TO 2030
FIGURE 12 THE ABLATION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE VENOUS DISEASES TREATMENT MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE EUROPE VENOUS DISEASES TREATMENT MARKET
FIGURE 14 EUROPE VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2022
FIGURE 19 EUROPE VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, LIFELINE CURVE
FIGURE 22 EUROPE VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2022
FIGURE 23 EUROPE VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2023-2030)
FIGURE 25 EUROPE VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE
FIGURE 26 EUROPE VENOUS DISEASES TREATMENT MARKET: BY END USER, 2022
FIGURE 27 EUROPE VENOUS DISEASES TREATMENT MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE VENOUS DISEASES TREATMENT MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE VENOUS DISEASES TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022)
FIGURE 36 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 EUROPE VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 EUROPE VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030)
FIGURE 39 EUROPE VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
